应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
OGN Organon & Co
盘后交易 04-28 16:04:52 EDT
13.33
+0.17
+1.29%
盘后
13.32
-0.01
-0.08%
16:02 EDT
最高
13.38
最低
13.18
成交量
3,672万
今开
13.19
昨收
13.16
日振幅
1.49%
总市值
35.00亿
流通市值
34.52亿
总股本
2.63亿
成交额
4.88亿
换手率
14.18%
流通股本
2.59亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
特定情况下交易终止 Organon & Co将向太阳制药美国控股支付1.2亿美元解约费
美股速递 · 04-27 18:12
特定情况下交易终止 Organon & Co将向太阳制药美国控股支付1.2亿美元解约费
异动解读 | 获太阳制药溢价收购，Organon盘前大涨14.92%
异动解读 · 04-27 16:06
异动解读 | 获太阳制药溢价收购，Organon盘前大涨14.92%
异动解读 | 获太阳制药溢价收购，Organon夜盘大涨15.99%
异动解读 · 04-27 15:34
异动解读 | 获太阳制药溢价收购，Organon夜盘大涨15.99%
印度太阳药业董事长：与Organon合作将助其进军尚未涉足的市场区域
美股速递 · 04-27 13:41
印度太阳药业董事长：与Organon合作将助其进军尚未涉足的市场区域
医药行业“新巨头”诞生！太阳制药斥资117.5亿美元收购Organon
智通财经 · 04-27 10:58
医药行业“新巨头”诞生！太阳制药斥资117.5亿美元收购Organon
美股夜盘 | 闪迪涨近3%，英特尔、台积电涨超2%；Organon续涨21%，上一交易日暴涨近31%
老虎资讯综合 · 04-27 08:14
美股夜盘 | 闪迪涨近3%，英特尔、台积电涨超2%；Organon续涨21%，上一交易日暴涨近31%
周五值得关注的股票：Lumentum、Coherent、保时捷
投资观察 · 04-10
周五值得关注的股票：Lumentum、Coherent、保时捷
Organon与Sebela制药达成协议，获授权引进无激素宫内节育器Miudella®
美股速递 · 02-23
Organon与Sebela制药达成协议，获授权引进无激素宫内节育器Miudella®
独立审查确认生物类似药采购无虞 Organon股价应声上涨1.7%
美股速递 · 02-20
独立审查确认生物类似药采购无虞 Organon股价应声上涨1.7%
Organon & Co独立审查：未发现往年从供应商处采购生物类似药时机存在不当行为的证据
美股速递 · 02-20
Organon & Co独立审查：未发现往年从供应商处采购生物类似药时机存在不当行为的证据
异动解读 | 第四季度利润与营收双双不及预期，Organon盘前大跌10.84%
异动解读 · 02-12
异动解读 | 第四季度利润与营收双双不及预期，Organon盘前大跌10.84%
财报前瞻｜Organon & Co本季度营收预计小幅下滑，机构观点偏谨慎
财报Agent · 02-05
财报前瞻｜Organon & Co本季度营收预计小幅下滑，机构观点偏谨慎
欧加农公司宣布美国FDA批准补充新药申请，延长Nexplanon®（依托孕烯植入剂）68毫克不透射线产品的使用期限
美股速递 · 01-17
欧加农公司宣布美国FDA批准补充新药申请，延长Nexplanon®（依托孕烯植入剂）68毫克不透射线产品的使用期限
Organon与第一三共达成Nilemdo®在法国、丹麦、冰岛、瑞典、芬兰及挪威商业化协议
美股速递 · 01-08
Organon与第一三共达成Nilemdo®在法国、丹麦、冰岛、瑞典、芬兰及挪威商业化协议
Henlius与Organon宣布美国FDA批准Poherdy®（Pertuzumab-Dpzb），首个在美国获批的Perjeta（Pertuzumab）生物类似药
美股速递 · 2025-11-17
Henlius与Organon宣布美国FDA批准Poherdy®（Pertuzumab-Dpzb），首个在美国获批的Perjeta（Pertuzumab）生物类似药
Organon & Co.2025财年第三财季实现净利润1.60亿美元，同比减少55.43%
市场透视 · 2025-11-17
Organon & Co.2025财年第三财季实现净利润1.60亿美元，同比减少55.43%
异动解读 | 摩根大通下调目标价，Organon & Co盘中大跌5.06%
异动解读 · 2025-11-11
异动解读 | 摩根大通下调目标价，Organon & Co盘中大跌5.06%
Organon 股价在盘前上涨 1.8%，因公司宣布与 Laborie 达成协议，将其 Jada 系统以高达 4.65 亿美元出售
美股速递 · 2025-11-07
Organon 股价在盘前上涨 1.8%，因公司宣布与 Laborie 达成协议，将其 Jada 系统以高达 4.65 亿美元出售
Organon & Co.盘中异动 急速上涨5.11%
市场透视 · 2025-02-26
Organon & Co.盘中异动 急速上涨5.11%
Organon & Co.盘中异动 股价大跌5.06%报15.50美元
市场透视 · 2025-02-15
Organon & Co.盘中异动 股价大跌5.06%报15.50美元
加载更多
公司概况
公司名称：
Organon & Co
所属市场：
NYSE
上市日期：
--
主营业务：
Organon & Co.是一家于2020年3月11日在特拉华州注册成立的公司。该公司是一家全球性的医疗保健公司，其使命是提供有影响力的药物和解决方案，让每一天都更健康。该公司在女性健康和普通药物领域拥有70多种产品组合，其中包括生物仿制药，专注于满足对女性有独特、不成比例或不同影响的健康需求，同时在140多个国家和地区扩大基本治疗的可及性。
发行价格：
--
{"stockData":{"symbol":"OGN","market":"US","secType":"STK","nameCN":"Organon & Co","latestPrice":13.33,"timestamp":1777406400000,"preClose":13.16,"halted":0,"volume":36716118,"hourTrading":{"tag":"盘后","latestPrice":13.32,"preClose":13.33,"latestTime":"16:02 EDT","volume":183557,"amount":2444979.0564429997,"timestamp":1777406545208,"change":-0.01,"changeRate":-0.00075,"amplitude":0.0015},"delay":0,"changeRate":0.012917933130699083,"floatShares":259000000,"shares":262600862,"eps":0.72,"marketStatus":"盘后交易","change":0.17,"latestTime":"04-28 16:04:52 EDT","open":13.19,"high":13.3757,"low":13.18,"amount":487521938.64111,"amplitude":0.014871,"askPrice":13.38,"askSize":404,"bidPrice":13.25,"bidSize":700,"shortable":3,"etf":0,"ttmEps":0.72,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1777420800000},"marketStatusCode":4,"adr":0,"exchange":"NYSE","adjPreClose":13.16,"dividendRate":0.006002,"preHourTrading":{"tag":"盘前","latestPrice":13.19,"preClose":13.16,"latestTime":"09:29 EDT","volume":615042,"amount":8094626.806032,"timestamp":1777382999915,"change":0.03,"changeRate":0.00228,"amplitude":0.011649},"postHourTrading":{"tag":"盘后","latestPrice":13.32,"preClose":13.33,"latestTime":"16:02 EDT","volume":183557,"amount":2444979.0564429997,"timestamp":1777406545208,"change":-0.01,"changeRate":-0.00075,"amplitude":0.0015},"volumeRatio":1.007743,"optionData":{"bulkOrders":[{"symbol":"OGN","call":true,"expireDate":1778817600000,"strike":"12.0","timestamp":1777385157040,"price":1.3,"volume":16471,"amount":2141230,"type":"+"},{"symbol":"OGN","call":true,"expireDate":1778817600000,"strike":"10.0","timestamp":1777385157040,"price":3.2,"volume":11871,"amount":3798720,"type":"-"}]},"impliedVol":0.0812,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/OGN","defaultTab":"news","newsList":[{"id":"1117334061","title":"特定情况下交易终止 Organon & Co将向太阳制药美国控股支付1.2亿美元解约费","url":"https://stock-news.laohu8.com/highlight/detail?id=1117334061","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117334061?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:12","pubTimestamp":1777284733,"startTime":"0","endTime":"0","summary":"根据最新提交至美国证券交易委员会的文件披露，若在特定情形下交易协议被终止，Organon & Co将需要向Sun Pharmaceutical Holdings USA支付高达1.2亿美元的终止费用。\n该条款明确了交易双方在意外情况下的责任归属，展现出合作协议中对风险管控的重视。这笔巨额解约费的设定，既体现了交易价值的重要性，也为可能出现的变数提供了明确的解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065170008.USD","LU2065171402.SGD","LU2065169927.USD","BK4585","OGN","LU2065171311.SGD","BK4588","BK4559","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135181552","title":"异动解读 | 获太阳制药溢价收购，Organon盘前大涨14.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135181552","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135181552?lang=zh_cn&edition=full","pubTime":"2026-04-27 16:06","pubTimestamp":1777277217,"startTime":"0","endTime":"0","summary":"消息面上，此次股价异动的直接原因是印度制药巨头太阳制药工业公司宣布将以全现金交易方式收购Organon。根据协议，太阳制药将以每股14.00美元的现金价格收购Organon的所有流通股，这一价格较Organon前一交易日的收盘价溢价超过24%。市场分析认为，这笔高溢价的收购要约显著提升了Organon的股东价值，是推动其股价在盘前交易时段强劲上涨的核心动力。收购预计将扩大太阳制药的国际业务版图，并使其获得Organon在女性健康、生物类似药及成熟药物领域的产品组合。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9ece825f4c5d1baec3e02266db9135cf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["OGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182099951","title":"异动解读 | 获太阳制药溢价收购，Organon夜盘大涨15.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=1182099951","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182099951?lang=zh_cn&edition=full","pubTime":"2026-04-27 15:34","pubTimestamp":1777275295,"startTime":"0","endTime":"0","summary":"根据协议，太阳制药将以每股14.00美元的价格收购Organon所有流通股，这一价格较Organon前一交易日的收盘价溢价超过24%。收购预计将扩大太阳制药的国际版图，并使其获得Organon在女性健康、生物类似药及成熟药物领域的产品组合，覆盖全球约140个国家。市场普遍认为，这笔高溢价的收购要约是推动Organon股价在夜盘大幅走高的核心动力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9ece825f4c5d1baec3e02266db9135cf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["OGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102141116","title":"印度太阳药业董事长：与Organon合作将助其进军尚未涉足的市场区域","url":"https://stock-news.laohu8.com/highlight/detail?id=1102141116","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102141116?lang=zh_cn&edition=full","pubTime":"2026-04-27 13:41","pubTimestamp":1777268471,"startTime":"0","endTime":"0","summary":"印度太阳药业董事长表示，与Organon & Co达成的合作协议将为公司提供宝贵机遇，使其能够在目前尚未开展业务的全球市场推出产品。这一战略合作将有效拓展太阳药业的地理覆盖范围，开辟新的增长空间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","LU2065171402.SGD","LU2065170008.USD","LU2065169927.USD","OGN","BK4559","LU2065171311.SGD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630355828","title":"医药行业“新巨头”诞生！太阳制药斥资117.5亿美元收购Organon","url":"https://stock-news.laohu8.com/highlight/detail?id=2630355828","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630355828?lang=zh_cn&edition=full","pubTime":"2026-04-27 10:58","pubTimestamp":1777258724,"startTime":"0","endTime":"0","summary":"根据协议，Organon 的股东将获得每股 14 美元的现金。该交易已获得两家公司董事会的批准，在获得监管机构批准和 Organon 股东批准的前提下，预计将于 2027 年初完成。截至 12 月 31 日的财年，Organon 报告的收入为 62 亿美元，调整后的息税折旧摊销前利润为 19 亿美元。对于投资者而言，这笔交易的成功与否，可能取决于太阳制药整合 Organon 产品组合、管理杠杆以及从其扩张后的全球平台中产生增长的能力。","market":"hk","thumbnail":"https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9ece825f4c5d1baec3e02266db9135cf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434189.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"医药行业“新巨头”诞生！太阳制药斥资117.5亿美元收购Organon","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","OGN","LU2065170008.USD","LU2065171311.SGD","LU2065171402.SGD","BK4007","LU2065169927.USD","BK1191","BK4588","BK1574","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120142490","title":"美股夜盘 | 闪迪涨近3%，英特尔、台积电涨超2%；Organon续涨21%，上一交易日暴涨近31%","url":"https://stock-news.laohu8.com/highlight/detail?id=1120142490","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120142490?lang=zh_cn&edition=full","pubTime":"2026-04-27 08:14","pubTimestamp":1777248893,"startTime":"0","endTime":"0","summary":"4月27日，美股夜盘时段，加密货币股普涨，$Strategy(MSTR)$、$BitMine Immersion Technologies Inc.(BMNR)$涨超2%，$、$Coinbase Global, Inc.(COIN)$、Cleanspark、$Robinhood(HOOD)$涨超1%。$英特尔(INTC)$续涨1%，上一交易日涨超23%；$台积电(TSM)$续涨2%，上一交易日涨超5%。Organon续涨21%，上一交易日暴涨近31%。有报道称印度Sun Pharmaceutical Industries计划收购该公司。","market":"us","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9ece825f4c5d1baec3e02266db9135cf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4554","LU1712237335.SGD","LU0823421416.USD","LU1211504680.USD","LU1868837722.USD","BK4579","LU2543165471.USD","OGN","LU0792757196.USD","LU1267930813.SGD","LU1989764748.USD","LU2247934214.USD","LU1868838027.USD","LU1989764664.SGD","BK4591","LU0321505439.SGD","LU0359201885.HKD","LU1989772840.SGD","TSMZ","LU0094547139.USD","LU0359201612.USD","LU2491050154.USD","IE0004091025.USD","BK4515","WNTR","MST","BK4543","MTYY","LU0056508442.USD","SGXZ99366536.SGD","BK4141","LU2125154935.USD","LU1623119135.USD","LU0965509283.SGD","LU2471134952.CNY","LU1989772923.USD","LU0082616367.USD","INTC","LU0321505868.SGD","LU2023250504.SGD","TSM","IE00BQXX3C00.GBP","LU1037948541.HKD","IE00BZ199S13.USD","LU0143863198.USD","LU0175139822.USD","LU1508157978.USD","BK4512","BK4535","LU2491049909.HKD","LU0384037296.USD","BK4529","BK4605","MSOO","MSII","LU0965509010.AUD","LU2471134796.USD","BK4505","LU2458330169.SGD","BK4527","LU0642271901.SGD","LU0719512351.SGD","LU0572939691.SGD","BK4534","LU0965508806.USD","LU2237443382.USD","TSMX","LU2092937221.SGD","LU0353189680.USD","MSTK","LU2360106780.USD","LU0689626769.HKD","LU0823414478.USD","LU2148611432.USD","LU0572940350.SGD","LU2133065610.SGD","BK4585","LU0158827948.USD","LU0965509101.SGD","LU2357125470.USD","LU2506951792.HKD","SG9999004220.SGD","LU0316494557.USD","LU0359202008.SGD","LU1037948897.HKD","LU2250418816.HKD","LU0124676726.USD","LU1316542783.SGD","BK4550","IE00BFXG0V08.USD","LU0109392836.USD","LU0882747503.HKD","IE00BQXX3D17.EUR","SMST","LU2089283258.USD","LU2041044095.USD","BK4602","LU0198837287.USD","LU2054465674.USD","LU1934455277.USD","IE00BQXX3F31.USD","LU2931357623.SGD","IE00BYQQ9H92.USD","LU2458330243.SGD","LU0081259029.USD","BK4548","IE00BKPKM429.USD","LU0264606111.USD","BK4588","BK4526","LU0158827781.USD","LU0861579265.USD","LU0323591593.USD","LU2294711713.HKD","IE000M9KFDE8.USD","LU2750360997.AUD","MSTR","LU1803068979.SGD","MSTU","LU0143863784.USD","MSTY","LU2237443622.USD","IE00BHPRN162.USD","BK4503","LU0541501648.USD","LU2663582299.SGD","LU2360108059.USD","BK4532","MSTZ","IE00BD6J9T35.USD","LU1323610961.USD","LU0823414551.USD","LU1852331112.SGD","SG9999000418.SGD","LU0348723411.USD","LU0345770308.USD","LU2028103732.USD","MSTW","LU0274383776.USD","LU0541502299.USD","LU2087625088.SGD","LU2089985449.USD","LU2237443978.SGD","IE0004445239.USD","IE00B3M56506.USD","LU1974910355.USD","LU0878005551.USD","LU1934455194.USD","IE0004086264.USD","TSMU","LU0238689110.USD","LU2750360641.GBP","LU0345770993.USD","LU2063271972.USD","BK4504","LU0289960550.SGD","LU2211814178.USD","IE00B5TLWC47.USD","LU2271345857.HKD","LU0878004406.USD","LU2471134879.HKD","LU2860962120.EUR","LU0889565833.HKD","MSST","BK4612","LU0889566641.SGD","MSDD","LU0823421333.USD","LU1917777945.USD","LU2111349929.HKD","IMST","LU2125154778.USD","LU1023057109.AUD","LU2237443549.SGD","SGXZ51526630.SGD","LU2023251221.USD","LU2360032135.SGD","LU2491050071.SGD","BK4575","BK4533","LU0488056044.USD","LU1868837565.USD","LU2089284900.SGD","LU2106854487.HKD","LU2249611893.SGD","LU0353189763.USD","LU2298321311.HKD","SGXZ81514606.USD","LU1934455863.HKD","LU2211815571.USD","TSMY","MSTX","LU0097036916.USD","LU2471134523.USD","LU1282649067.USD","LU1282649810.SGD","MSTP","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158435342","title":"周五值得关注的股票：Lumentum、Coherent、保时捷","url":"https://stock-news.laohu8.com/highlight/detail?id=1158435342","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158435342?lang=zh_cn&edition=full","pubTime":"2026-04-10 17:31","pubTimestamp":1775813500,"startTime":"0","endTime":"0","summary":"Lumentum与Coherent：这两家获得英伟达支持的光学设备制造商在盘前交易中上涨。摩根大通分析师上调了对其股票的目标价。区域性银行对利率预期的变化尤为敏感，因此它们属于可能因任何通胀意外数据而波动的股票之列。通胀降温及利率下降往往有助于提升抵押贷款的可获得性并促进房屋销售。保时捷：这家豪华汽车品牌的交付量出现下滑，原因是其燃油动力718系列车型停产以及美国电动汽车激励政策的终止对销量造成了打击。其股价小幅下跌。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c200b8aad634771b0fcbc3537c6826aa","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0310800379.SGD","LU2264538146.SGD","LU2505996681.GBP","LU1839511570.USD","LU1244550494.USD","LU0390134368.USD","LU2896262040.SGD","LU2237438978.USD","LU2491050071.SGD","BK4504","LU0265550946.USD","LU1861215975.USD","BK4592","LU0158827948.USD","LU0528227936.USD","LU1629891620.HKD","LU2237957811.SGD","LU0345770993.USD","LU1429558221.USD","LU1868836757.USD","LU0070217475.USD","LU0274383776.USD","LU0082616367.USD","BK4581","LU0957791311.USD","LITE","LU0256863902.USD","LU1066053197.SGD","LU2092627202.USD","LU2756315664.SGD","IE00BKVL7J92.USD","IE00B1XK9C88.USD","LU0557290698.USD","SG9999014880.SGD","IE00B4JS1V06.HKD","LU1323610961.USD","LU1116320737.USD","LU0345768740.USD","LU0964807845.USD","NVDY","LU0823421416.USD","LU1934455194.USD","IE00B4YYXB79.USD","BK4598","NVDG","LITX","LU2360106780.USD","LU0211327993.USD","LU1035775433.USD","SG9999015952.SGD","IE00B19Z9505.USD","LU2456880835.USD","LU0061474705.USD","LU0106261612.USD","LU2543165471.USD","IE00B1BXHZ80.USD","LU0210528500.USD","LU0708995401.HKD","LU0276348264.USD","LU0786609619.USD","LU1496350171.SGD","IE0004445239.USD","LU1400636491.USD","LU1935043536.SGD","LU0094547139.USD","LU0048584097.USD","LU1066051811.HKD","LU1861127337.USD","IE00BJLML261.HKD","BK4148","LU0882574139.USD","LU2087625088.SGD","BK4548","SG9999015341.SGD","IE00B66KJ199.SGD","LU2023250330.USD","IE00BJJMRX11.SGD","LU2506951792.HKD","SG9999015358.SGD","LU1778281490.HKD","LU2430703251.USD","3NVD.UK","LU0861579265.USD","IE0031619046.USD","LU2491049909.HKD","LU1989772840.SGD","BK4020","LU0080751232.USD","LU0820561909.HKD","LU2242650005.HKD","LU2125909247.SGD","NVD2.UK","IE00BJJMRY28.SGD","LU0208291251.USD","LU1244550221.USD","LU2191332357.HKD","NVDS.UK","SG9999002224.SGD","LU1316542783.SGD","LU0097036916.USD","LU1116320901.HKD","LU2417539215.USD","SG9999014575.USD","LU1366333091.USD","LU0265550359.USD","IE00BHPRN162.USD","LU0444971666.USD","LU0942090050.USD","LU0823414551.USD","IE00BMPRXN33.USD","SG9999018865.SGD","LU1803068979.SGD","NVDS","LU1992135472.HKD","LU0215105999.USD","SG9999015978.USD","LU2125154935.USD","LU1201861249.SGD","IE00B19Z8W00.USD","LU1267930490.SGD","LU2168564495.EUR","LU2286300806.USD","LU0266013472.USD","LU0289960550.SGD","LU2505996509.AUD","LU1400636574.HKD","LU2552382058.USD","LU0225283273.USD","LU0965509010.AUD","IE00BQXX3F31.USD","BK4088","LU0128525929.USD","IE0004086264.USD","BK4503","LU2750360641.GBP","IE00BWXC8680.SGD","LU0251132253.USD","LU2065170008.USD","LU2054465674.USD","SG9999017495.SGD","LU0642271901.SGD","LU0289961442.SGD","LU0640476718.USD","NVIW.SI","LU2089284900.SGD","HK0000304797.USD","ANV","LU0077335932.USD","LU2111349929.HKD","COHX","LU0130517989.USD","LU0466842654.USD","LU0708994859.HKD","IE00B19Z8X17.USD","BK4588","LU2552382215.SGD","LU0210536198.USD","LU2592432038.USD","LU2750360997.AUD","LU0154236417.USD","LU2125909759.SGD","LU2413666426.HKD","LU0965509101.SGD","LU1868836591.USD","LU1934455863.HKD","IE00B3SWFQ91.USD","LU1145028129.USD","LU1868837136.USD","BK4157","LU1821325948.USD","LU2471134523.USD","LU1571399168.USD","LU0820561818.USD","LU0342679015.USD","LU2361044865.SGD","LU1923622291.USD","LU0314104364.USD","LU0477156953.USD","LU1261432733.SGD","LU2063271972.USD","LU1633808545.USD","2NVD.UK","SG9999001424.SGD","IE00BK4W5L77.USD","LU0354030438.USD","LU1720051017.SGD","DHI","IE0034235188.USD","LU1084165304.USD","LU2360032135.SGD","HK0000306685.HKD","LU0788109477.HKD","LU0205194284.USD","LU2083900584.USD","LU2430703178.SGD","BK4587","IE0034235303.USD","LU1868836914.USD","LU1037948897.HKD","LU0267386448.USD","LU2213496289.HKD","LU0683600562.USD","IE00BDRTCR15.USD","SG9999014567.USD","LU2089985449.USD","LU2097344431.USD","LU0353189763.USD","BK4166","BK4608","BK4614","IE00B3S45H60.SGD","IE0004091025.USD","LU2326559502.SGD","HK0000306701.USD","NVDX","LU2473716301.USD","IE0001KFT4U8.USD","LU0238689110.USD","LU1242518857.USD","LU1923622614.USD","SG9999000418.SGD","LU0240877869.USD","LU1935043023.USD","IE00BJTD4V19.USD","LU0061475181.USD","LU2092937148.SGD","BK4612","BK4532","LU1974910355.USD","HK0000320264.USD","BK4549","IE00BZ199S13.USD","BK4596","SG9999014898.SGD","LU1127390331.HKD","LU2602419157.SGD","IE00BFSS7M15.SGD","LU0029864427.USD","LU0648001328.SGD","LU2462157665.USD","LU1119994496.HKD","LU1989772923.USD","IE00BK4W5M84.HKD","LU1935042215.USD","LU2023250504.SGD","LU2272731600.USD","LU0787776722.HKD","LU2461242641.AUD","LU2361045086.USD","LU0353189680.USD","LU1551013425.SGD","IE00BQXX3C00.GBP","LU0823421333.USD","LU2125154778.USD","LU2108987350.USD","LU1988902786.USD","LU1935042991.SGD","LU2746668461.USD","LU2931357623.SGD","LU1699723380.USD","BK4529","IE0003U64NQ7.SGD","LU2272731782.SGD","LU2290526834.HKD","LU1814569148.SGD","BK4579","LU0724617625.USD","LU1917777945.USD","HK0000914660.USD","LU1914381329.SGD","LU1951198990.SGD","LU0079474960.USD","NVII","LU2420271590.USD","SG9999014906.USD","BK4534","LU0130102774.USD","POAHY","GB00BDT5M118.USD","NVDW","LU2089283258.USD","IE00B775SV38.USD","LU0985320562.USD","LU2413666699.HKD","LU0310799852.SGD","IE00BQXX3D17.EUR","LU0006306889.USD","LU0210533765.USD","LU2430703095.HKD","LU1934455277.USD","LU2250418816.HKD","IE0005OL40V9.USD","LU1791710582.SGD","HK0000304805.HKD","LU2077746001.SGD","SG9999014914.USD","LU1674673428.USD","LU0345769128.USD","LU2294711713.HKD","LU0234572021.USD","NVDU","SGXZ23171101.USD","NVDB","SG9999004303.SGD","LU2065169927.USD","LU2242649171.HKD","LU1153585028.USD","BK4585","LU0109391861.USD","BK4551","LU2746668974.SGD","LU0198837287.USD","LU2168564149.EUR","IE00BDCRKT87.USD","LU2087621335.USD","LU2168564065.EUR","IE00B7KXQ091.USD","LU1791807156.HKD","BK4141","LU1691799644.USD","HK0000914686.HKD","LU0256863811.USD","LU0170899867.USD","LU1992135399.USD","BK4561","LU0106261372.USD","LU1989764748.USD","LU0965508806.USD","SGXZ31699556.SGD","LU0823434740.USD","LU0823414478.USD","LU1366192091.USD","IE00B19Z4B17.USD","ALLY","LU1244550577.SGD","OGN","IE00BN29S564.USD","SNVD.UK","LU0057025933.USD","LU0070302665.USD","SG9999014542.SGD","LU2471134879.HKD","NVDQ","IE0009356076.USD","LU0417517546.SGD","LU2552382132.HKD","LU0211331839.USD","LU1868837300.USD","BK4554","IE000ITXATA3.USD","BK4527","BK4559","LU0012050646.USD","LU2249611893.SGD","LU1548497426.USD","LU1861220033.SGD","LU2491050154.USD","LU2211815571.USD","LU2237957902.USD","LU0211328371.USD","LU0096362180.USD","LU1712237335.SGD","LU2168563687.JPY","LU0107464264.USD","LU2463028550.USD","LU2065171402.SGD","LU2168564222.USD","LU0289739343.SGD","LU2433249047.HKD","LU0187121727.USD","LU1267930730.SGD","LU0354030511.USD","IE00BD6J9T35.USD","LU2471134796.USD","LU1852331112.SGD","NVD","SGXZ51526630.SGD","LU0868494617.USD","BK4550","LU0096364046.USD","LU2487616109.SGD","LU0240878834.USD","LU2125909593.SGD","LU1202635105.USD","IE000YTNTUN2.SGD","SGXZ99366536.SGD","IE00B775H168.HKD","LU1935042488.USD","LU2097344357.USD","SGXZ81514606.USD","LU1064131342.USD","LU1721428933.USD","LU0823434583.USD","LU0081259029.USD","LU0061474960.USD","IE0004445015.USD","LU0011850046.USD","LU0323591593.USD","LU1815336760.USD","LU0205193047.USD","LU1951200564.SGD","LU0979878070.USD","IE00BYXW3230.USD","SG9999014559.SGD","LU1989764664.SGD","LU2236285917.USD","LU0511384066.AUD","LU2361044949.HKD","LU0158827781.USD","IE00B3M56506.USD","LU0719512351.SGD","LU2452424414.USD","LU2403377893.USD","NVD3.UK","SG9999015986.USD","LU0320765059.SGD","NVDL","IE00BZ1G4Q59.USD","LU1400636657.SGD","IE00BMPRXR70.SGD","LU2065171311.SGD","IE00B5949003.HKD","LU1983260115.SGD","LU1242518931.SGD","LU1066051225.USD","LU0124676726.USD","LU1267930573.SGD","LU2322448791.USD","LU1623119135.USD","LU1551013342.USD","NVDD","BK4211","LU2247934214.USD","LU0072462426.USD","IE00BFSS8Q28.SGD","LU0127658192.USD","LU2023251221.USD","HK0000320223.HKD","IE00BJTD4N35.SGD","LU1815333072.USD","LU0672654240.SGD","LU0472753341.HKD","LU0203201768.USD","SG9999015945.SGD","LU2272731865.HKD","LU0820562030.AUD","LU1668664300.SGD","LU0444973449.USD","LU1232071149.USD","LU0345769631.USD","LU1066051498.USD","IE0034235295.USD","LU0348723411.USD","IE00BMPRXQ63.HKD","LEN","LU0957808578.USD","LU0203202063.USD","IE000W1ABFV2.USD","COHR","LU0308772762.SGD","LU2458330243.SGD","LU1720051108.HKD","LU0943347566.SGD","LU2244417387.USD","LU1923623000.USD","LU0234570918.USD","LU0980610538.SGD","LU0347712357.USD","LU0689626769.HKD","LU2381873111.SGD","SG9999002232.USD","LU1280957306.USD","IE00BKPKM429.USD","LU2028103732.USD","LU1645745479.HKD","LU0889565833.HKD","LU0494093205.USD","NVDO","LU0056508442.USD","LU2125909916.SGD","LU1791710400.SGD","LU2357125470.USD","LU0476273544.USD","LU0106831901.USD","LU0965509283.SGD","LU0868494708.USD","SG9999018857.SGD","LU1670756490.USD","LU0053666078.USD","LU0157215616.USD","LU0316494557.USD","LU1642822529.SGD","LU2360107168.USD","LU0320765489.SGD","BK4605","LU0109392836.USD","BK4543","LU1718418525.SGD","LU1674673691.USD","LU0069063385.USD","IE0009G5SDU7.USD","LU2756315318.SGD","IE00B7SZL793.SGD","LU1496350502.SGD","LU1037948541.HKD","IE00BKDWB100.SGD","LU2322448957.HKD","LU1435385759.SGD","LU2265009873.SGD","IE000KEQY171.SGD","BK4533","DIPS","LU2458330169.SGD","LU0689472784.USD","LU1069344957.HKD","LU2271345857.HKD","BK4567","LU0345768153.USD","LU2471134952.CNY","LU2860962120.EUR","LU0175139822.USD","LU2357305700.SGD","BK4007","LU1804176565.USD","LU2106854487.HKD","TFC","LU0345770308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187634909","title":"Organon与Sebela制药达成协议，获授权引进无激素宫内节育器Miudella®","url":"https://stock-news.laohu8.com/highlight/detail?id=1187634909","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187634909?lang=zh_cn&edition=full","pubTime":"2026-02-23 20:30","pubTimestamp":1771849813,"startTime":"0","endTime":"0","summary":"Organon & Co（简称：Organon）已正式签署协议，获得Sebela Pharmaceuticals旗下无激素宫内节育器Miudella®的授权许可。此次合作将拓展Organon在女性健康领域的产品组合，为全球女性提供更多避孕选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGN","BK4588","LU2065171311.SGD","LU2065169927.USD","BK4559","BK4585","LU2065170008.USD","BK4007","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121548213","title":"独立审查确认生物类似药采购无虞 Organon股价应声上涨1.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1121548213","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121548213?lang=zh_cn&edition=full","pubTime":"2026-02-20 22:31","pubTimestamp":1771597898,"startTime":"0","endTime":"0","summary":"在第三方独立审查机构公布对Organon历史生物类似药采购流程的评估结果后，该公司股价今日呈现显著上扬态势。审查报告明确指出，其过往采购操作符合规范要求，未发现任何违规行为。这一结论消除了市场对潜在合规风险的疑虑，投资者信心随之提振。\n受此利好消息影响，Organon股票当日收盘涨幅达1.7%，成交量同步放大。生物类似药作为公司战略布局的重要板块，此次审查结果为其后续业务拓展奠定了合规基础。市场分析师认为，该公告有效缓解了投资者对监管风险的担忧，为企业估值修复提供了支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4559","LU2065170008.USD","OGN","BK4007","LU2065171311.SGD","LU2065171402.SGD","LU2065169927.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121700994","title":"Organon & Co独立审查：未发现往年从供应商处采购生物类似药时机存在不当行为的证据","url":"https://stock-news.laohu8.com/highlight/detail?id=1121700994","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121700994?lang=zh_cn&edition=full","pubTime":"2026-02-20 20:38","pubTimestamp":1771591094,"startTime":"0","endTime":"0","summary":"一项针对Organon & Co的独立审查结果显示，调查方未找到任何证据，能够证明该公司在往年从供应商处采购生物类似药的时机选择上存在不当行为。此次审查旨在澄清相关采购操作的时间点是否合规，最终结论表明，未发现存在问题的依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU2065170008.USD","LU2065169927.USD","LU2065171402.SGD","OGN","BK4588","LU2065171311.SGD","BK4585","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187621050","title":"异动解读 | 第四季度利润与营收双双不及预期，Organon盘前大跌10.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=1187621050","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187621050?lang=zh_cn&edition=full","pubTime":"2026-02-12 21:20","pubTimestamp":1770902424,"startTime":"0","endTime":"0","summary":"Organon & Co (OGN) 今日盘前股价大幅下挫10.84%，市场表现引发关注。消息面上，该公司公布的第四季度业绩表现疲软。财报显示，其第四季度调整后利润为每股63美分，低于市场预期的每股73美分；同时，第四季度营收为15亿美元，也低于预期的15.4亿美元。利润与营收双双不及预期，是导致股价在盘前交易时段承压大跌的主要原因。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["OGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175621004","title":"财报前瞻｜Organon & Co本季度营收预计小幅下滑，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1175621004","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175621004?lang=zh_cn&edition=full","pubTime":"2026-02-05 11:24","pubTimestamp":1770261845,"startTime":"0","endTime":"0","summary":"Organon & Co将于2026年02月12日发布最新季度财报，市场关注收入动能与盈利质量的变化，以及核心品类的结构调整带来的影响。市场普遍预期Organon & Co本季度营收为15.39亿美元，同比下降3.45%；息税前利润为3.80亿美元，同比下降7.34%；调整后每股收益为0.73美元，同比下降15.43%。上季度Organon & Co实现营收16.02亿美元，同比增长1.26%；毛利率54.24%；归属母公司的净利润1.60亿美元，净利率9.99%，环比增长10.34%；调整后每股收益1.01美元，同比增长16.09%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜Organon & Co本季度营收预计小幅下滑，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153205452","title":"欧加农公司宣布美国FDA批准补充新药申请，延长Nexplanon®（依托孕烯植入剂）68毫克不透射线产品的使用期限","url":"https://stock-news.laohu8.com/highlight/detail?id=1153205452","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153205452?lang=zh_cn&edition=full","pubTime":"2026-01-17 10:12","pubTimestamp":1768615963,"startTime":"0","endTime":"0","summary":"欧加农公司近日宣布，其补充新药申请已获得美国食品药品监督管理局（FDA）的批准。此次获批意味着Nexplanon®（依托孕烯植入剂）68毫克不透射线产品的使用期限得以延长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4007","LU2065171402.SGD","BK4585","LU2065169927.USD","LU2065171311.SGD","OGN","LU2065170008.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136506367","title":"Organon与第一三共达成Nilemdo®在法国、丹麦、冰岛、瑞典、芬兰及挪威商业化协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1136506367","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136506367?lang=zh_cn&edition=full","pubTime":"2026-01-08 14:33","pubTimestamp":1767854021,"startTime":"0","endTime":"0","summary":"Organon & Co近日宣布与日本制药巨头第一三共签署重要商业合作协议，获得其降胆固醇药物Nilemdo在法国、丹麦、冰岛、瑞典、芬兰和挪威六个欧洲国家的独家商业化权利。此次合作将显著拓展Organon在欧洲心血管疾病治疗领域的产品组合，同时强化第一三共创新药物在全球市场的渗透力。这一战略布局不仅彰显Organon对欧洲高价值医药市场的深耕决心，更凸显其通过外部合作快速扩充特色药品管线的商业模式。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU2065170008.USD","LU2065169927.USD","LU2065171402.SGD","OGN","BK4588","LU2065171311.SGD","BK4585","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155289447","title":"Henlius与Organon宣布美国FDA批准Poherdy®（Pertuzumab-Dpzb），首个在美国获批的Perjeta（Pertuzumab）生物类似药","url":"https://stock-news.laohu8.com/highlight/detail?id=1155289447","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155289447?lang=zh_cn&edition=full","pubTime":"2025-11-17 18:32","pubTimestamp":1763375530,"startTime":"0","endTime":"0","summary":"Henlius与Organon宣布，美国FDA已批准Poherdy®（Pertuzumab-Dpzb），这是首个在美国获批的Perjeta（Pertuzumab）生物类似药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2065171311.SGD","LU2065171402.SGD","BK4007","BK4585","LU2065169927.USD","LU2065170008.USD","OGN","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584399624","title":"Organon & Co.2025财年第三财季实现净利润1.60亿美元，同比减少55.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584399624","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584399624?lang=zh_cn&edition=full","pubTime":"2025-11-17 00:01","pubTimestamp":1763308866,"startTime":"0","endTime":"0","summary":"11月17日，Organon & Co.公布财报，公告显示公司2025财年第三财季净利润为1.60亿美元，同比减少55.43%；其中营业收入为16.02亿美元，同比增加1.26%，每股基本收益为0.62美元。从资产负债表来看，Organon & Co.总负债126.46亿美元，其中短期债务45.00百万美元，资产负债比为1.08，流动比率为1.76。机构评级：截至2025年11月17日，当前有6家机构对Organon & Co.目标价做出预测，其中目标均价为9.67美元，其中最低目标价为5.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117000126a6fd6c9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117000126a6fd6c9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181983631","title":"异动解读 | 摩根大通下调目标价，Organon & Co盘中大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=1181983631","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181983631?lang=zh_cn&edition=full","pubTime":"2025-11-11 23:34","pubTimestamp":1762875267,"startTime":"0","endTime":"0","summary":"周二盘中，Organon & Co股价出现大幅下跌，跌幅达5.06%，引发投资者关注。造成股价下跌的主要原因可能是华尔街知名投行摩根大通对该公司股票的最新评估。根据最新报告，摩根大通分析师将Organon & Co的目标价从14美元下调至12美元。投资者可能会根据这一新的分析调整其投资策略，导致抛售压力增加。Organon & Co今日的股价大跌似乎直接反映了市场对这一分析师评级变化的反应。投资者应密切关注公司未来的财务表现和市场动态，以评估这一下跌是否会持续。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["OGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186695436","title":"Organon 股价在盘前上涨 1.8%，因公司宣布与 Laborie 达成协议，将其 Jada 系统以高达 4.65 亿美元出售","url":"https://stock-news.laohu8.com/highlight/detail?id=1186695436","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186695436?lang=zh_cn&edition=full","pubTime":"2025-11-07 20:36","pubTimestamp":1762518985,"startTime":"0","endTime":"0","summary":"Organon 股价在盘前上涨 1.8%，因公司宣布与 Laborie 达成协议，将其 Jada 系统以高达 4.65 亿美元出售。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2065171311.SGD","LU2065169927.USD","BK4007","LU2065170008.USD","LU2065171402.SGD","BK4559","OGN","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514017881","title":"Organon & Co.盘中异动 急速上涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514017881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514017881?lang=zh_cn&edition=full","pubTime":"2025-02-26 01:29","pubTimestamp":1740504592,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日01时29分，Organon & Co.股票出现波动，股价快速上涨5.11%。截至发稿，该股报15.85美元/股，成交量154.74万股，换手率0.60%，振幅4.58%。Organon & Co.股票所在的制药行业中，整体涨幅为1.33%。Organon & Co.公司简介：Organon & Co 是一家以科学为基础的全球制药公司，通过妇女保健，生物仿制药和知名品牌的处方治疗组合，开发和提供健康解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226012952a253aec9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226012952a253aec9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171402.SGD","LU2065169927.USD","LU2065170008.USD","BK4588","LU2065171311.SGD","BK4559","OGN","BK4585","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511137596","title":"Organon & Co.盘中异动 股价大跌5.06%报15.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511137596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511137596?lang=zh_cn&edition=full","pubTime":"2025-02-15 01:58","pubTimestamp":1739555939,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日01时58分，Organon & Co.股票出现异动，股价大幅跳水5.06%。截至发稿，该股报15.50美元/股，成交量153.16万股，换手率0.59%，振幅6.04%。Organon & Co.股票所在的制药行业中，整体跌幅为1.14%。Organon & Co.公司简介：Organon & Co 是一家以科学为基础的全球制药公司，通过妇女保健，生物仿制药和知名品牌的处方治疗组合，开发和提供健康解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215015859a2462d74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215015859a2462d74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065169927.USD","BK4588","BK4585","BK4559","BK4007","OGN","LU2065170008.USD","LU2065171402.SGD","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.organon.com","stockEarnings":[{"period":"1week","weight":0.4212},{"period":"1month","weight":1.2534},{"period":"3month","weight":0.4622},{"period":"6month","weight":1.0757},{"period":"1year","weight":0.0787},{"period":"ytd","weight":0.8354}],"compareEarnings":[{"period":"1week","weight":0.0091},{"period":"1month","weight":0.1279},{"period":"3month","weight":0.0283},{"period":"6month","weight":0.0404},{"period":"1year","weight":0.2988},{"period":"ytd","weight":0.0488}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Organon & Co.是一家于2020年3月11日在特拉华州注册成立的公司。该公司是一家全球性的医疗保健公司，其使命是提供有影响力的药物和解决方案，让每一天都更健康。该公司在女性健康和普通药物领域拥有70多种产品组合，其中包括生物仿制药，专注于满足对女性有独特、不成比例或不同影响的健康需求，同时在140多个国家和地区扩大基本治疗的可及性。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.103066},{"month":2,"riseRate":0.4,"avgChangeRate":-0.031967},{"month":3,"riseRate":0.2,"avgChangeRate":-0.040746},{"month":4,"riseRate":0.4,"avgChangeRate":0.205603},{"month":5,"riseRate":0.5,"avgChangeRate":-0.044845},{"month":6,"riseRate":0.5,"avgChangeRate":-0.004329},{"month":7,"riseRate":0.6,"avgChangeRate":0.002574},{"month":8,"riseRate":0.4,"avgChangeRate":0.012058},{"month":9,"riseRate":0.2,"avgChangeRate":-0.086411},{"month":10,"riseRate":0.4,"avgChangeRate":-0.058949},{"month":11,"riseRate":0.2,"avgChangeRate":-0.091617},{"month":12,"riseRate":0.6,"avgChangeRate":0.051819}],"exchange":"NYSE","name":"Organon & Co","nameEN":"Organon & Co"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Organon & Co(OGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Organon & Co(OGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Organon & Co,OGN,Organon & Co股票,Organon & Co股票老虎,Organon & Co股票老虎国际,Organon & Co行情,Organon & Co股票行情,Organon & Co股价,Organon & Co股市,Organon & Co股票价格,Organon & Co股票交易,Organon & Co股票购买,Organon & Co股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Organon & Co(OGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Organon & Co(OGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}